Effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats

The objective of this study was to investigate the effects of a novel form of biotin (magnesium biotinate) on serum glucose, lipid profile, and hepatic lipid metabolism-related protein levels in rats. Forty-two rats were divided into six groups and fed a standard diet-based egg white powdered diet s...

詳細記述

保存先:
書誌詳細
主要な著者: Sahin, Kazim, Orhan, Cemal, Kucuk, Osman, Erten, Fusun, Tuzcu, Mehmet, Sahin, Nurhan, Perez Ojalvo, Sara, Komorowski, James Richard
フォーマット: Article ou chapitre numérique
言語:Français
出版事項: 2021
主題:
オンライン・アクセス:Accès Université d'Orléans et IFPM
Accès Université d'Orléans et IFPM
id cairn-MRH_341_0009
record_format cairn
spelling cairn-MRH_341_0009MRHMagnesium Research https://stm.cairn.info/revue-magnesium-research-2021-1-page-9?lang=en https://doi.org/10.1684/mrh.2021.0480 Effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats Sahin, KazimOrhan, CemalKucuk, OsmanErten, FusunTuzcu, MehmetSahin, NurhanPerez Ojalvo, SaraKomorowski, James Richard2021 D-biotinglucoseinsulinlipid parametersmagnesium biotinatefre Magnesium Research | 34 | 1 | 2021-01-01 | p. 9-19 | 0953-1424 MRH_34196 The objective of this study was to investigate the effects of a novel form of biotin (magnesium biotinate) on serum glucose, lipid profile, and hepatic lipid metabolism-related protein levels in rats. Forty-two rats were divided into six groups and fed a standard diet-based egg white powdered diet supplemented with either d-biotin at 0.01, 1, or 100 mg/kg BW or magnesium biotinate at 0.01, 1, or 100 mg/kg BW for 35 days. Neither form of biotin influenced (p > 0.05) serum glucose or insulin concentrations. Serum total cholesterol and triglyceride decreased with biotin from both sources (p < 0.05). Concentrations were lower with magnesium biotinate when comparing the 1 mg/kg dose (p < 0.05). Serum, liver, and brain biotin and liver cyclic guanosine monophosphate (cGMP) concentrations were greater when rats were treated with magnesium biotinate versus d-biotin, particularly when comparing the 1 and 100 mg/kg dose groups (p < 0.05). Both biotin forms decreased the liver SREBP-1c and FAS and increased AMPK-α1, ACC-1, ACC-2, PCC, and MCC levels (p < 0.05). The magnitudes of responses were more emphasized with magnesium biotinate. Magnesium biotinate, compared with a commercial d-biotin, is more effective in reducing serum lipid concentrations and regulating protein levels of lipid metabolism-related biomarkers.Cairn free access
language Français
format Article ou chapitre numérique
building 0/Bibliothèque numérique/
1/Bibliothèque numérique/Cairn/
topic D-biotin
glucose
insulin
lipid parameters
magnesium biotinate
spellingShingle D-biotin
glucose
insulin
lipid parameters
magnesium biotinate
Sahin, Kazim
Orhan, Cemal
Kucuk, Osman
Erten, Fusun
Tuzcu, Mehmet
Sahin, Nurhan
Perez Ojalvo, Sara
Komorowski, James Richard
Effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats
topic_facet D-biotin
glucose
insulin
lipid parameters
magnesium biotinate
description The objective of this study was to investigate the effects of a novel form of biotin (magnesium biotinate) on serum glucose, lipid profile, and hepatic lipid metabolism-related protein levels in rats. Forty-two rats were divided into six groups and fed a standard diet-based egg white powdered diet supplemented with either d-biotin at 0.01, 1, or 100 mg/kg BW or magnesium biotinate at 0.01, 1, or 100 mg/kg BW for 35 days. Neither form of biotin influenced (p > 0.05) serum glucose or insulin concentrations. Serum total cholesterol and triglyceride decreased with biotin from both sources (p < 0.05). Concentrations were lower with magnesium biotinate when comparing the 1 mg/kg dose (p < 0.05). Serum, liver, and brain biotin and liver cyclic guanosine monophosphate (cGMP) concentrations were greater when rats were treated with magnesium biotinate versus d-biotin, particularly when comparing the 1 and 100 mg/kg dose groups (p < 0.05). Both biotin forms decreased the liver SREBP-1c and FAS and increased AMPK-α1, ACC-1, ACC-2, PCC, and MCC levels (p < 0.05). The magnitudes of responses were more emphasized with magnesium biotinate. Magnesium biotinate, compared with a commercial d-biotin, is more effective in reducing serum lipid concentrations and regulating protein levels of lipid metabolism-related biomarkers.
author Sahin, Kazim
Orhan, Cemal
Kucuk, Osman
Erten, Fusun
Tuzcu, Mehmet
Sahin, Nurhan
Perez Ojalvo, Sara
Komorowski, James Richard
author_facet Sahin, Kazim
Orhan, Cemal
Kucuk, Osman
Erten, Fusun
Tuzcu, Mehmet
Sahin, Nurhan
Perez Ojalvo, Sara
Komorowski, James Richard
author_sort Sahin, Kazim
title Effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats
title_short Effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats
title_full Effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats
title_fullStr Effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats
title_full_unstemmed Effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats
title_sort effects of magnesium biotinate supplementation on serum insulin, glucose and lipid parameters along with liver protein levels of lipid metabolism in rats
publishDate 2021
container_title
container_issue
url https://ezproxy.univ-orleans.fr/login?url=https://stm.cairn.info/revue-magnesium-research-2021-1-page-9?lang=en
https://ezproxy.univ-orleans.fr/login?url=https://doi.org/10.1684/mrh.2021.0480
_version_ 1877246235877834752